|

CD19 t-haNK- IV Administration Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • ImmunityBio, Inc.1

Indications

  • Relapsed B-Cell Non-Hodgkin Lymphoma1
  • Cancer1

Other1 trial

Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.